Rhamnolipids: fermentation products of glucose with Pseudomonas bacteria

€80M expansion adds downstream fermentation for drug‑substance manufacturing, creates ~50 jobs; follows rhamnolipids plant and boosts biotech scale‑up and sustainability.

The program analyzes wastewater to detect health threats early, enhancing public health responses and aligning with EU health strategies.

The program analyzes wastewater to detect health threats early, enhancing public health responses and aligning with EU health strategies.

The new facility produces industrial-scale rhamnolipid biosurfactants from renewable corn feedstocks, offering sustainable alternatives for various industries and reinforcing Evonik's biotechnology capabilities.

The new plant in Slovakia will produce sustainable, biodegradable rhamnolipids for cleaning and personal care, enhancing the biotech hub and supporting Evonik's shift to system solutions.

Investing a three-digit million-euro sum, the new plant will produce bio-based, biodegradable rhamnolipids, enhancing partnerships and market position in biosurfactants. Completion is expected in two years.